
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
COVID-19-associated opportunistic infections: a snapshot on the current reports
Amir Abdoli, Shahab Falahi, Azra Kenarkoohi
Clinical and Experimental Medicine (2021) Vol. 22, Iss. 3, pp. 327-346
Open Access | Times Cited: 129
Amir Abdoli, Shahab Falahi, Azra Kenarkoohi
Clinical and Experimental Medicine (2021) Vol. 22, Iss. 3, pp. 327-346
Open Access | Times Cited: 129
Showing 1-25 of 129 citing articles:
Selective phosphodiesterase 4 inhibitor roflumilast reduces inflammation and lung injury in models of betacoronavirus infection in mice
Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Vinícius Amorim Beltrami, Flávia Rayssa Braga Martins, Débora Gonzaga Martins, et al.
Inflammation Research (2025) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the C OVID-19 Pandemic
Nuria Trevijano‐Contador, Alba Torres-Cano, Cristina Carballo-González, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 37
Nuria Trevijano‐Contador, Alba Torres-Cano, Cristina Carballo-González, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 37
In Silico Development of Novel Benzofuran-1,3,4-Oxadiazoles as Lead Inhibitors of M. tuberculosis Polyketide Synthase 13
Ali Irfan, Shah Faisal, Ameer Fawad Zahoor, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 829-829
Open Access | Times Cited: 22
Ali Irfan, Shah Faisal, Ameer Fawad Zahoor, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 829-829
Open Access | Times Cited: 22
Viral reactivations and co-infections in COVID-19 patients: a systematic review
Jenny Yeon Hee Kim, Martín Ragusa, Fernando Tortosa, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Jenny Yeon Hee Kim, Martín Ragusa, Fernando Tortosa, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Protective Efficacy of Anti-Hyr1p Monoclonal Antibody against Systemic Candidiasis Due to Multi-Drug-Resistant Candida auris
Shakti Singh, Ashley Barbarino, Eman G. Youssef, et al.
Journal of Fungi (2023) Vol. 9, Iss. 1, pp. 103-103
Open Access | Times Cited: 16
Shakti Singh, Ashley Barbarino, Eman G. Youssef, et al.
Journal of Fungi (2023) Vol. 9, Iss. 1, pp. 103-103
Open Access | Times Cited: 16
Strongyloides stercoralis combined with concurrent multiple pathogens infections in an immunosuppressed patient: a case report
Jim Fang, Hongli Fang, Penghao Guo, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Jim Fang, Hongli Fang, Penghao Guo, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Enhanced biocidal efficacy of alcohol based disinfectants with salt additives
Euna Oh, Hyerin Shin, Sumin Han, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Euna Oh, Hyerin Shin, Sumin Han, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
First documentation of Aspergillus welwitschiae in COVID-19-associated pulmonary aspergillosis in the Americas
Tiago Alexandre Cocio, Vivian Caso Coelho, Gilda Maria Bárbaro Del Negro, et al.
Revista do Instituto de Medicina Tropical de São Paulo (2025) Vol. 67
Open Access
Tiago Alexandre Cocio, Vivian Caso Coelho, Gilda Maria Bárbaro Del Negro, et al.
Revista do Instituto de Medicina Tropical de São Paulo (2025) Vol. 67
Open Access
Environmental Mold Management in Negative‐Pressure Isolation Wards During the COVID‐19 Pandemic: A Potential Indicator of COVID‐19‐Associated Pulmonary Aspergillosis
Jin Yeong Hong, Jae‐Hoon Ko, Jinyoung Yang, et al.
Indoor Air (2025) Vol. 2025, Iss. 1
Open Access
Jin Yeong Hong, Jae‐Hoon Ko, Jinyoung Yang, et al.
Indoor Air (2025) Vol. 2025, Iss. 1
Open Access
Candida in COVID-19: Gut-Lung Axis, Dysbiosis, and Infections
Milena Kordalewska, David S. Perlin
Current Fungal Infection Reports (2023)
Open Access | Times Cited: 12
Milena Kordalewska, David S. Perlin
Current Fungal Infection Reports (2023)
Open Access | Times Cited: 12
Sufficient Sleep, Time of Vaccination, and Vaccine Efficacy: A Systematic Review of the Current Evidence and a Proposal for COVID-19 Vaccination.
Esmail Rayatdoost, Mohammad Rahmanian, Mohammad Sadegh Sanie, et al.
PubMed (2022) Vol. 95, Iss. 2, pp. 221-235
Closed Access | Times Cited: 19
Esmail Rayatdoost, Mohammad Rahmanian, Mohammad Sadegh Sanie, et al.
PubMed (2022) Vol. 95, Iss. 2, pp. 221-235
Closed Access | Times Cited: 19
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
Laura C. García-Carnero, Héctor M. Mora‐Montes
Journal of Fungi (2022) Vol. 8, Iss. 5, pp. 445-445
Open Access | Times Cited: 18
Laura C. García-Carnero, Héctor M. Mora‐Montes
Journal of Fungi (2022) Vol. 8, Iss. 5, pp. 445-445
Open Access | Times Cited: 18
Design of an artificial neural network to predict mortality among COVID-19 patients
Mostafa Shanbehzadeh, Raoof Nopour, Hadi Kazemi-Arpanahi
Informatics in Medicine Unlocked (2022) Vol. 31, pp. 100983-100983
Open Access | Times Cited: 17
Mostafa Shanbehzadeh, Raoof Nopour, Hadi Kazemi-Arpanahi
Informatics in Medicine Unlocked (2022) Vol. 31, pp. 100983-100983
Open Access | Times Cited: 17
COVID-19-associated fungal infections in Iran: A systematic review
Tina Nazari, Fatemeh Sadeghi, Alireza Izadi, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0271333-e0271333
Open Access | Times Cited: 17
Tina Nazari, Fatemeh Sadeghi, Alireza Izadi, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0271333-e0271333
Open Access | Times Cited: 17
Phototherapies for COVID-19-associated opportunistic oral infections
Giuseppina Berlingieri, Cristina Maria Arvate Álvares, Rafael Verardi Serrano, et al.
Photodiagnosis and Photodynamic Therapy (2021) Vol. 37, pp. 102678-102678
Open Access | Times Cited: 22
Giuseppina Berlingieri, Cristina Maria Arvate Álvares, Rafael Verardi Serrano, et al.
Photodiagnosis and Photodynamic Therapy (2021) Vol. 37, pp. 102678-102678
Open Access | Times Cited: 22
Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients
Francesca Raffaelli, Eloisa Sofia Tanzarella, Gennaro De Pascale, et al.
Journal of Fungi (2022) Vol. 8, Iss. 4, pp. 415-415
Open Access | Times Cited: 15
Francesca Raffaelli, Eloisa Sofia Tanzarella, Gennaro De Pascale, et al.
Journal of Fungi (2022) Vol. 8, Iss. 4, pp. 415-415
Open Access | Times Cited: 15
Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1
Tyler G. Normile, Maurizio Del Poeta
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Tyler G. Normile, Maurizio Del Poeta
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Current Landscape of Coccidioidomycosis
Ryan Boro, Prema Iyer, Maciej A. Walczak
Journal of Fungi (2022) Vol. 8, Iss. 4, pp. 413-413
Open Access | Times Cited: 14
Ryan Boro, Prema Iyer, Maciej A. Walczak
Journal of Fungi (2022) Vol. 8, Iss. 4, pp. 413-413
Open Access | Times Cited: 14
Toxoplasmosis and symptoms severity in patients with COVID-19 in referral centers in Northern Iran
Ali Geraili, Alireza Badirzadeh, Maryam Sadeghi, et al.
Journal of Parasitic Diseases (2022) Vol. 47, Iss. 1, pp. 185-191
Open Access | Times Cited: 14
Ali Geraili, Alireza Badirzadeh, Maryam Sadeghi, et al.
Journal of Parasitic Diseases (2022) Vol. 47, Iss. 1, pp. 185-191
Open Access | Times Cited: 14
Toxoplasma gondii, HBV, and HCV co‐infection and their correlation with CD4 cells among Iranian HIV‐positive patients
Ahmadreza Bazmjoo, Mohammad Aref Bagherzadeh, Rahim Raoofi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8
Ahmadreza Bazmjoo, Mohammad Aref Bagherzadeh, Rahim Raoofi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 8
Biogenic silver nanoparticles eradicate of Pseudomonas aeruginosa and Methicillin-resistant Staphylococcus aureus (MRSA) isolated from the sputum of COVID-19 patients
Nahed M. Hawsawi, Arshad Mahdi Hamad, Sahar Naji Rashid, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Nahed M. Hawsawi, Arshad Mahdi Hamad, Sahar Naji Rashid, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Immunosuppressive therapy and COVID‐19 infection in patients with NMOSD
Un Wai Choi, Xiwen Ai, Hongyan Li, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Un Wai Choi, Xiwen Ai, Hongyan Li, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Impact of latent toxoplasmosis on pneumonic and non-pneumonic COVID-19 patients with estimation of relevant oxidative stress biomarkers
Doaa A. Hamdy, Ragaey A Eid, Heba Abdel‐Tawab, et al.
Folia Parasitologica (2024) Vol. 71
Open Access | Times Cited: 2
Doaa A. Hamdy, Ragaey A Eid, Heba Abdel‐Tawab, et al.
Folia Parasitologica (2024) Vol. 71
Open Access | Times Cited: 2
Effect of Rodent Control Program on Incidence of Zoonotic Cutaneous Leishmaniasis, Iran
Amir Abdoli, Samaneh Mazaherifar, Kavous Solhjoo, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 2
Amir Abdoli, Samaneh Mazaherifar, Kavous Solhjoo, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 2
COVID-19 Vaccination, Peltzman Effect and Possible Increase in Highrisk Behaviors: A Growing Concern Related to Risk Compensation and Reduced Compliance to Public Health Protective Measures after Vaccines Rollout
Shahab Falahi, Jasem Mohamadi, Hojjat Sayyadi, et al.
Infectious Disorders - Drug Targets (2022) Vol. 22, Iss. 8
Closed Access | Times Cited: 12
Shahab Falahi, Jasem Mohamadi, Hojjat Sayyadi, et al.
Infectious Disorders - Drug Targets (2022) Vol. 22, Iss. 8
Closed Access | Times Cited: 12